Tatsuhiko Shigeto

Hirosaki, 0368562, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Survival and prognostic factors in vaginal cancer: an analysis of 2016-2020 nationwide data.

Survival and prognostic factors in vaginal cancer: an analysis of 2016-2020 nationwide data.

Journal: International journal of clinical oncology

Published: October 28, 2025

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: October 23, 2025

Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

Journal: Journal of gynecologic oncology

Published: August 27, 2025

Utility of circulating human papillomavirus DNA as a biomarker for detection and prognosis of cervical cancer in Japanese patients.

Utility of circulating human papillomavirus DNA as a biomarker for detection and prognosis of cervical cancer in Japanese patients.

Journal: International journal of clinical oncology

Published: February 18, 2025

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study).

Journal: Cancers

Published: October 13, 2024

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study).

Journal: Cancers

Published: August 29, 2023

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).

Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study).

Journal: International journal of clinical oncology

Published: May 04, 2022

Preventive effect of daikenchuto, a traditional Japanese herbal medicine, on onset of ileus after gynecological surgery for malignant tumors.

Preventive effect of daikenchuto, a traditional Japanese herbal medicine, on onset of ileus after gynecological surgery for malignant tumors.

Journal: Asia-Pacific journal of clinical oncology

Published: August 29, 2019

Dysgerminoma developing from an ectopic ovary in a patient with WAGR syndrome: A case report.

Dysgerminoma developing from an ectopic ovary in a patient with WAGR syndrome: A case report.

Journal: Molecular and clinical oncology

Published: May 18, 2016

A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer.

A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: March 02, 2016

Differences in the sensitivity of ovarian cancer to photodynamic therapy and the mechanisms for those differences.

Differences in the sensitivity of ovarian cancer to photodynamic therapy and the mechanisms for those differences.

Journal: Oncology letters

Published: December 12, 2015

Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling.

Inhibitory effect of carbonyl reductase 1 on ovarian cancer growth via tumor necrosis factor receptor signaling.

Journal: International journal of oncology

Published: August 12, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026